Arno Therapeutics Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
4
- Stock Symbol
-
ARNI
- Investments
-
1
Arno Therapeutics General Information
Description
Arno Therapeutics Inc operates as a biopharmaceutical company. It develops drug candidates to treat patients with cancer and other life-threatening diseases. It develops pre-clinical and clinical-stage products under the following names: Onapristone, AR-42, and AR-12. Onapristone is indicated for endometrial, prostate, and breast cancer indications; AR-42 is provided for hematological malignancies and solid tumor indications; and AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets.
Contact Information
Website
www.arnothera.comCorporate Office
- 200 Route 31 North
- Suite 104
- Flemington, NJ 08822
- United States
Corporate Office
- 200 Route 31 North
- Suite 104
- Flemington, NJ 08822
- United States
Arno Therapeutics Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 3.5K |
Arno Therapeutics Financials Summary
As of 30-Sep-2016, Arno Therapeutics has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2016 | FY 2015 31-Dec-2015 | FY 2014 31-Dec-2014 | FY 2013 31-Dec-2013 |
|---|---|---|---|---|
| EV | 18,603 | 6,927 | 2,036 | 60,199 |
| Revenue | 0 | |||
| EBITDA | (13,650) | (11,480) | 7,742 | (21,092) |
| Net Income | (13,695) | (11,508) | 7,771 | (39,657) |
| Total Assets | 2,356 | 361 | 8,248 | 26,883 |
| Total Debt | 5 | 2,098 | 11 | 0 |
Arno Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Arno Therapeutics Comparisons
Industry
Financing
Details
Arno Therapeutics Competitors (10)
One of Arno Therapeutics’s 10 competitors is Vertex Pharmaceuticals, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals | Formerly VC-backed | Boston, MA | ||||
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands | ||||
| Aura Biosciences | Formerly VC-backed | Boston, MA | ||||
| Spark Therapeutics | Formerly VC-backed | Philadelphia, PA |
Arno Therapeutics Patents
Arno Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11613555-B2 | Methods for onapristone synthesis dehydration and deprotection | Active | 30-Nov-2016 | ||
| US-20180148471-A1 | Methods for onapristone synthesis dehydration and deprotection | Inactive | 30-Nov-2016 | ||
| US-20210221838-A1 | Methods for onapristone synthesis dehydration and deprotection | Active | 30-Nov-2016 | ||
| WO-2018102369-A1 | Methods for onapristone synthesis dehydration and deprotection | Inactive | 30-Nov-2016 | ||
| WO-2017165315-A1 | Onapristone metabolite compositions and methods | Inactive | 21-Mar-2016 | A61K31/575 |
Arno Therapeutics Signals
Arno Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Arno Therapeutics Acquisitions (1)
Arno Therapeutics’s most recent deal was a Merger/Acquisition with Laurier International. The deal was made on 04-Jun-2008.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Laurier International | 04-Jun-2008 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Arno Therapeutics FAQs
-
When was Arno Therapeutics founded?
Arno Therapeutics was founded in 2005.
-
Where is Arno Therapeutics headquartered?
Arno Therapeutics is headquartered in Flemington, NJ.
-
What is the size of Arno Therapeutics?
Arno Therapeutics has 4 total employees.
-
What industry is Arno Therapeutics in?
Arno Therapeutics’s primary industry is Drug Discovery.
-
Is Arno Therapeutics a private or public company?
Arno Therapeutics is a Public company.
-
What is Arno Therapeutics’s stock symbol?
The ticker symbol for Arno Therapeutics is ARNI.
-
Who are Arno Therapeutics’s competitors?
Vertex Pharmaceuticals, Sarepta Therapeutics, Cristal Therapeutics, Aura Biosciences, and Spark Therapeutics are some of the 10 competitors of Arno Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process